Home » Health Care

Press Releases

BIO Applauds House Committee Vote to Repeal IPAB
March 6 2012

BIO applauded the House Energy and Commerce Committee’s passage of the Medicare...

BIO Announces Policy Panel Keynote Session for 2011 BIO International Convention
April 19 2011

Democratic and Republican party leaders and strategists will share their differing...

The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
February 9 2011

BIO announces that former Senator John B. Breaux (D-LA), former Member, Senate Finance...

Challenges in Reimbursement Hamper Development of Novel Diagnostics
January 6 2011

BIO releases a report by Health Advances on the limitations of the nation’s...

Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011

The 2011 BIO International Convention will highlight the latest trends and the newest...

BIO Announces Initial Selection of Life Sciences Companies to Present at the 13th Annual BIO CEO & Investor Conference
December 13 2010
BIO Applauds Obama Administration’s Guidance for Therapeutic Discovery Project Program
May 21 2010
BIO Hosts Numerous High-Ranking Public Officials at 2010 BIO International Convention
May 4 2010
New BIO Report Highlights Value of Biotechnology to Individuals and Society
May 4 2010

A new report issued by the Biotechnology Industry Organization underscores how biotechnology...

BIO Urges Senate Committee on Finance Not to Limit Patients’ Access to Therapies
April 12 2007

S. 3 Would Weaken Medicare Part D Drug Benefit

New Survey Counters Claims Regarding Single Source Therapies in Medicare Part D
February 26 2007

Private Sector Negotiations for Medicare Part D Provide Savings and Access to Innovative...

Medicare Drug Coverage Will Expand Access to Biotech Products
November 25 2003

Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the...

Report Details Biotechnology's Contributions On Baby-Boomer Health, Quality of Life
October 5 2000
Clinton Plan Another Step In Debate That's Critically Important To Seniors And Biotech
June 29 1999
President's Medicare Proposal Could Be Key to Both Seniors' and Biotechnology Industry's Health
June 26 1999
BIO to Testify at Senate Finance Committee Hearing on Medicare Modernization
June 22 1999
BIO Adds Medicare Section To Its Web Site
May 11 1999
BIO Strongly Backs U.S. Sen. Bennett's Efforts To Protect Patient Confidentiality
April 27 1999
BIO '99 To Explore Debate Over Financing Drug Benefits For Seniors
April 22 1999
BIO Responds To New Kennedy/Stark Medicare Bill
April 20 1999
Biotech Industry Adopts Statement Opposing Discriminatory Misuse Of Medical Information
April 8 1999
Kennedy, Johnson Bill Could Cause Medicine Deficit
March 31 1999
BIO Statement on Medicare Reform
March 29 1999
Price Controls Promise Only To Undermine Biotech Drug Development
February 11 1999
BIO Statement on Iceland Genetic Data
January 15 1999
BIO Urges President's Bioethics Advisory Panel To Consider Issues Raised By Stem Cell Research
November 12 1998
Senate Votes Down Effort to Expedite Ban on Human Cloning
February 11 1998
BIO Responds to Cloning Report
January 7 1998
BIO Supports Ban on Cloning of Humans, Seeks Medical Research Protection
June 7 1997
International Biotechnology Community Supports Genetic Privacy - BIO Seeks White House Support
June 5 1997
BIO Reacts to Sheep Cloning Experiment
February 23 1997
BIO Calls for Strong Protections for Genetic Information
February 1 1997

Letters, Testimony & Comments

BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter
March 1 2013
  BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter, submitted Friday,...
Medicaid, Children’s Health Insurance Programs, and Exchanges
February 21 2013
Ms. Marilyn Tavenner, B.S.N., M.H.A. Acting Administrator Centers for Medicare & Medicaid Services Room 445–G, Hubert H....
CED: BIO's Comments in response to the Centers for Medicare and Medicaid Services’ (CMS) Draft Guidance for the Public, Industry, and CMS Staff Coverage with Evidence Development in the context of coverage decision
January 28 2013
Dear Dr. Jacques:            The Biotechnology Industry Organization (BIO) is pleased...
340B: BIO’s Comments to HRSA Regarding the Burden to Conduct 340B Audits
December 21 2012
The Biotechnology Industry Organization (“BIO”) is pleased to submit the following comments in response to “Proposed...
EHB: BIO’s Comments on the Essential Health Benefits Proposed Rule
December 21 2012
          The Biotechnology Industry Organization (BIO) is pleased to submit the following...
More Letters, Testimony & Comments →

Press Releases

BIO Applauds House Committee Vote to Repeal IPAB
March 6 2012
Washington, DC (March 6, 2012) – The Biotechnology Industry Organization (BIO) applauded the House Energy and...
BIO Announces Policy Panel Keynote Session for 2011 BIO International Convention
April 19 2011
WASHINGTON, D.C. (April 19, 2011) - Democratic and Republican party leaders and strategists will share their...
The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
February 9 2011
WASHINGTON, D.C. (Wednesday, February 09, 2011) -The Biotechnology Industry Organization (BIO) today announced that...
Challenges in Reimbursement Hamper Development of Novel Diagnostics
January 6 2011
WASHINGTON, D.C. (Thursday, January 06, 2011) - The Biotechnology Industry Organization (BIO) released today a report...
Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011
WASHINGTON, D.C. (Monday, January 03, 2011) - The Biotechnology Industry Organization (BIO) announced today that...
More Press Releases →